<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="160159">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01013701</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00029405</org_study_id>
    <nct_id>NCT01013701</nct_id>
  </id_info>
  <brief_title>Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease</brief_title>
  <official_title>A Randomized, Doubel-Blind, Placebo-Controlled, Parallel-Group, Single Center Study to Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluticasone furoate is being studied to determine whether treatment with a topical nasal
      steroid, in patients with existing nasal polyps , can not only improve symptoms but also
      suppress the recurrence of clinically significant nasal polyp obstruction and prevent
      surgical intervention.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the effect of once daily nasal steroid therapy with fluticasone furoate nasal spray (110 mcg/day) in suppressing nasal polyp-induced symptoms over the course of 16 weeks in patients presenting to the clinic with active nasal polypoid disease.</measure>
    <time_frame>18 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the efficacy and safety of once daily nasal steroid therapy with fluticasone furoate nasal spray in suppressing the signs of recurrence of nasal polyps over the course of 16 weeks.</measure>
    <time_frame>18 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Patients With Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>Fluticasone Furoate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nasal steroid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>nasal spray vehicle without drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fluticasone furoate</intervention_name>
    <description>nasal steroid spray</description>
    <arm_group_label>Fluticasone Furoate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>nasal steroid vehicle without drug</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female patients 18-70 years of age, in general good health.

          2. Current evidence of nasal polyps on physical exam. 3) Able to understand the protocol
             and comply with instructions. 4) Have a negative urine pregnancy test in women of
             childbearing potential. 5) Women of childbearing potential must be on an acceptable
             method of birth control or willing to remain abstinent through the duration of the
             study.

        Exclusion Criteria:

          1. Are pregnant and/or breast-feeding.

          2. History of alcohol or drug abuse in the past year.

          3. Signs and symptoms suggestive of fulminant bacterial sinusitis (fever &gt;101 F,
             persistent severe unilateral facial or tooth pain, facial swelling).

          4. Allergies to nasal corticosteroids

          5. .Other chronic significant medical illnesses 6) Maintenance oral prednisone therapy
             for other chronic medical conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2009</verification_date>
  <lastchanged_date>November 13, 2009</lastchanged_date>
  <firstreceived_date>November 13, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Peter S. Creticos, M.D.</name_title>
    <organization>Johns Hopkins University</organization>
  </responsible_party>
  <keyword>nasal polyps</keyword>
  <keyword>nasal steroid</keyword>
  <keyword>fluticasone furoate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fluticasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
